HIV-associated lipodystrophy

HIV-associated lipodystrophy (pronunciation: /ˌaɪtʃaɪˈviː əˈsoʊʃieɪtɪd ˌlɪpoʊˈdɪstrəfi/) is a condition that affects individuals who are infected with the HIV.

Etymology

The term "lipodystrophy" is derived from the Greek words "lipos" meaning fat and "dystrophy" meaning abnormal growth or development. The prefix "HIV-associated" indicates that the condition is related to an infection with the HIV.

Definition

HIV-associated lipodystrophy is characterized by the abnormal distribution of fat in the body, which can lead to a variety of health problems. This condition is often associated with the use of certain antiretroviral medications, which are used to manage HIV infection.

Symptoms

Symptoms of HIV-associated lipodystrophy can vary widely, but often include loss of fat in the face, arms, and legs (lipoatrophy), accumulation of fat in the abdomen and other areas (lipohypertrophy), and metabolic complications such as insulin resistance, dyslipidemia, and cardiovascular disease.

Treatment

Treatment for HIV-associated lipodystrophy often involves changes to the individual's antiretroviral therapy regimen, as well as interventions to manage metabolic complications. This may include the use of medications to manage cholesterol and triglyceride levels, as well as lifestyle modifications such as diet and exercise.

Related Terms

• Lipodystrophy
• Antiretroviral therapy
• Insulin resistance
• Dyslipidemia
• Cardiovascular disease

External links

• Medical encyclopedia article on HIV-associated lipodystrophy
• Wikipedia's article - HIV-associated lipodystrophy

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski